Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

Abstract

Background We did a randomised phase III trial comparing external irradiation alone and external irradiation combined with an analogue of luteinising-hormone releasing hormone (LHRH) to investigate the added value of long-term androgen suppression in locally advanced prostate cancer. Methods Between 1987 and 1995, 415 patients were randomly assigned radiotherapy alone or radiotherapy plus immediate androgen suppression. Eligible patients had T1-2 tumours of WHO grade 3 or T3-4 N0-1 M0 tumours; the median age of participants was 71 years (range 51-80). In both treatment groups, 50 Gy radiation was delivered to the pelvis over 5 weeks, and 20 Gy over 2 weeks as a prostatic boost. Goserelin (3.6 mg subcutaneously every 4 weeks) was started on the first day of irradiation and continued for 3 years; cyproterone acetate (150 mg orally) was given for 1 month starting 1 week before the first goserelin injection. The primary endpoint was clinical disease-free survival. Analyses were by intention to treat. Findings 412 patients had evaluable data, with median follow-up of 66 months (range 1-126). 5-year clinical disease-free survival was 40% (95% CI 32-48) in the radiotherapy-alone group and 74% (67-81) in the combined-treatment group (p=0.0001). 5-year overall survival was 62% (52-72) and 78% (72-84), respectively (p=0.0002) and 5-year specific survival 79% (72-86) and 94% (90-98). Interpretation Immediate androgen suppression with an LHRH analogue given during and for 3 years after e…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(02)09408-4

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 27 references

Research works printed but not linked: 3

  1. Bagshaw, 1988, Status of radiation treatment of prostate cancer at Standford University, Monogr Natl Cancer Inst, 7, 47
  2. Goldenberg, 1995, Randomized, controlled study of neoadjuvant reversible androgen withdrawal therapy with cyproterone acetate in the surgical management of localized prostate cancer, J Urol, 153, 254A
  3. Wolmark, 2000, The role of radiotherapy and tamoxifen in the management of node negative invasive breast cancer-1?0 cm treated with lumpectomy, Proc Am Soc Clin Oncol, 19, 70a

Cited by

See all 1,686

Metadata

Authors
Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., Mattelaer, J., Torecilla, J. L., Pfeffer, J. R., Cutajar, C. L., Zurlo, A., & Pierart, M.
Affiliations
  • Centre Hospitalier Universitaire de Grenoble (FR)
  • European Organisation for Research and Treatment of Cancer (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Princess Margaret Cancer Centre (CA)
  • Centre Hospitalier Universitaire Vaudois (CH)
  • Ospedale San Giovanni Bellinzona (CH)
  • Rambam Health Care Campus (IL)
  • St. Luke's Hospital (MT)
Corresponding author
Bolla, Michel
Venue
The Lancet
Publisher
Elsevier BV
Published
2002-07
Volume
360
Issue
9327
Pages
103-108
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2144498681
Cited by
1,686
References
27
Citations by year
2026: 8 · 2025: 12 · 2024: 10 · 2023: 21 · 2022: 25 · 2021: 29 · 2020: 31 · 2019: 37 · 2018: 42 · 2017: 50 · 2016: 58 · 2015: 61 · 2014: 78 · 2013: 83 · 2012: 116
FWCI
74.64
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • IRIS (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
  • AstraZeneca
  • National Cancer Institute
Topics
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
locally advanced prostate cancer, androgen deprivation therapy, luteinizing hormone-releasing hormone analogue, goserelin, cyproterone acetate, external beam radiotherapy, disease-free survival, overall survival, adjuvant endocrine therapy
MeSH terms
Aged, Aged, 80 and over, Humans, Male, Middle Aged, Prostatic Neoplasms, Time Factors, Goserelin, Disease-Free Survival, Antineoplastic Agents, Hormonal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. https://app.cochat.ai/papers/10.1016/s0140-6736(02)09408-4
The paper
Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., Mattelaer, J., Torecilla, J. L., Pfeffer, J. R., Cutajar, C. L., Zurlo, A., & Pierart, M. (2002). Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. The Lancet. https://doi.org/10.1016/s0140-6736(02)09408-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.